“C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways”, J Appl Oral Sci, vol. 31, p. e20220404, Feb. 2023, doi: 10.1590/1678-7757-2022-0404.